⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL44613 | 1.00 | — | — | |
| SCHEMBL164325 | 1.00 | — | — | |
| SCHEMBL30619156 | 1.00 | ALDH1A1 (0.39) | — | |
| SCHEMBL30073966 | 0.97 | — | — | |
| Bromide SCHEMBL31312527 | 0.97 | — | — | |
| SCHEMBL28284839 | 0.97 | — | — | |
| Water SCHEMBL31216399 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL31312544 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL5272501 | 0.97 | — | — | |
| Fluoride SCHEMBL28084078 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109689051-B | Use of inhibitors of mitochondrial activity for the treatment of acute myeloid leukemia with poor prognosis | 蒙特利尔大学 | 2022-03-29 | — | — | CN | disclosed |
| US-10451595-B2 | Indicating devices based on lateral diffusion of a mobile phase through a non-porous stationary phase | JP LABORATORIES, INC (US) | 2019-10-22 | — | — | US | disclosed |
| US-9859442-B2 | Metal oxide semiconductor layer forming composition, and method for producing metal oxide semiconductor layer using same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-01-02 | — | — | US | disclosed |
| WO-2017161119-A1 | SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION | H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) | 2017-09-21 | — | — | WO | disclosed |
| US-20170162699-A1 | METAL OXIDE SEMICONDUCTOR LAYER FORMING COMPOSITION, AND METHOD FOR PRODUCING METAL OXIDE SEMICONDUCTOR LAYER USING SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170162699-A1 | METAL OXIDE SEMICONDUCTOR LAYER FORMING COMPOSITION, AND METHOD FOR PRODUCING METAL OXIDE SEMICONDUCTOR LAYER USING SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| EP-3171394-A1 | METAL OXIDE SEMICONDUCTOR LAYER FORMING COMPOSITION, AND METHOD FOR PRODUCING METAL OXIDE SEMICONDUCTOR LAYER USING SAME | Nissan Chemical Industries, Ltd. (JP) | 2017-05-24 | — | — | EP | disclosed |
| EP-3100031-A1 | INDICATING DEVICES BASED ON LATERAL DIFFUSION OF A MOBILE PHASE THROUGH A NON-POROUS STATIONARY PHASE | JP LABORATORIES, INC. (US) | 2016-12-07 | — | — | EP | disclosed |
| US-20160349224-A1 | INDICATING DEVICES BASED ON LATERAL DIFFUSION OF A MOBILE PHASE THROUGH A NON-POROUS STATIONARY PHASE | JP LABORATORIES, INC (US) | 2016-12-01 | — | — | US | disclosed |
| WO-2016133935-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC. (US) | 2016-08-25 | — | — | WO | disclosed |
| US-7169932-B2 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis | PFIZER INC. (US) | 2007-01-30 | — | — | US | disclosed |
| EP-1739082-A1 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | Agouron Pharmaceuticals , Inc. (US) | 2007-01-03 | — | — | EP | disclosed |
| US-20050250707-A1 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | CANAN KOCH STACIE S | 2005-11-10 | — | — | US | disclosed |
| US-6953858-B2 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | AGOURON PHARMACEUTICALS, INC. (US) | 2005-10-11 | — | — | US | disclosed |
| US-20040171842-A1 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis | PFIZER INC | 2004-09-02 | — | — | US | disclosed |
| US-20030153507-A1 | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | AGOURON PHARMACEUTICALS, INC. | 2003-08-14 | — | — | US | disclosed |
| EP-0799713-B1 | Thermal transfer donor element comprising a colourless sublimable compound and image forming process | MINNESOTA MINING & MFG (US) | 2000-07-19 | — | — | EP | disclosed |
| US-5747217-A | GRAPHIC ARTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| US-5717042-A | IN AN ALKANE SOLVENT USING A SCEONDARY AMINE TRANSFER AGENT AND ANIONIC INITIATOR | BRIDGESTONE/FIRESTONE, INC. (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0799713-A1 | Thermal transfer donor element comprising a colourless sublimable compound and image forming process | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-10-08 | — | — | EP | disclosed |